<DOC>
	<DOC>NCT01298544</DOC>
	<brief_summary>In 2005, Wyeth conducted study 0887X-101518 (NCT00488826) in which Chinese infants received either Prevenar alone (Group 1), Prevenar given with a Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccine (Group 2) or DTaP alone (Group 3). This follow up study (at least 3 years after the last vaccination) will assess the antibody concentrations in children who previously completed Wyeth study 0887X-101518.</brief_summary>
	<brief_title>A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male or female subjects who participated in and completed Wyeth study 0887X 101518. Healthy subject as determined by medical history, physical examination, and judgment of the investigator. Vaccination with any licensed or investigational pneumococcal vaccine since completion of Wyeth study 0887X 101518. History of culture proven invasive disease caused by S pneumoniae since the completion of Wyeth study 0887X 101518. Known or suspected immune deficiency or suppression since participation in Wyeth study 0887X 101518.</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Prevenar</keyword>
	<keyword>Pneumococcal disease</keyword>
</DOC>